Home   |  İrtibat   |  Yerler
Safe Infusion Therapy (TR)
 

Literatür

Bertolini G, Confalonieri M, Rossi, Simini B, Gorini M, Corrado A. Cost of the COPD. Differences between intensive care unit and respiratory intermediate care unit. Res Med 2005,(99): 894-900

Burchardi H, Schneider H. Economic Aspects of Severe Sepsis: A Review of Intensive Care Unit Costs, Cost of Illness and Cost effectiveness of Therapy. Adis International, PharmacoEconomics 2004; 22(12): 793-813(21).

Bouchoucha et al. Deep venous thrombosis associated with acute hematogenous osteomyelitis in children. Orthop Traumatol Surg Res. 2010 Dec; 96(8): 890-3., Boucher 2010

Centers for Disease Control and Prevention (CDC). Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR 2002; 51 (No. RR-16) See also Infect Control Hosp Epidemiol 2002; 23 (suppl): S3-S40; Am J Infect Control 2002; 30 (8):1-46

Centers for Disease Control and Prevention (CDC).Guideline for the Prevention of Intravascular Catheter-Related Infections. 2011

Centers for Disease Control and Prevention (CDC). Methicillinresistant Staphylococcus Aureus (MRSA) Infections.

Cohen J, Brun-Buisson C, Torres A, Jorgensen J. Scientific Reviews. Diagnosis of infection in sepsis: An evidence-based review. Critical Care Medicine 2004, (32) 11: 466-494

Dougherty L. Central Venous Access Devices: Care and Management. Blackwell Publishing, Oxford, 2006

Ducel G, Beraud C, Benassouli. Les nouveaux risques infectieux. Revue Futuribles, 1995, 203: 5–32.

European Centre for Disease Prevention and Control. Prevalence of MRSA in Europe 2008.

Gabriel J. Infusion therapy. Part two: Prevention and management of complications. Nurs Stand. 2008; 22(32): 41-8

Gastmeier P, Geffers C, Brandt C, Zuschneid I, Sohr D, Schwab F, Behnke M, Daschner F, Rüden H. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect. 2006 Sep; 64(1): 16-22

Gianino MM, Vallino A, Minniti D, Abbona F, Mineccia C, Silvaplana P, Zotti CM. A method to determine hospital costs associated with nosocomial infections (transl). Ann Ig., 2007;19(4): 381-92

Grayson ML, Jarvie LJ, Martin R, Johnson PD, Jodoin ME, McMullan C, Gregory RH, Bellis K, Cunnington K, Wilson FL, Quin D, Kelly AM, Hand Hygiene Study Group, Hand Hygiene Statewide Roll-out Group. Significant reductions in methicillin-resistant Staphylococcus aureus bacteraemia and clinical isolates associated with a multisite, hand hygiene culture-change program and subsequent successful statewide roll-out. Victorian Quality Council Med J Aust, June 2, 2008; 188(11): 633-40

Guerin K, Wagner J, Rains K, Bessesen M. Reduction in cenral line-associated bloodstream infections by implementation of a postinsertion care bundle. Am J Infect Control 2010 Aug; 38(6):430-3

Haley RW, Culver DH, White JW, Morgan WM, Emori TG. The nationwide nosomical infection rate. A new need for vital statistics. Am J Epidemiol. Feb 1985; 121(2): 159-167

Hall K, Farr B. Diagnosis and management of long-term central venous catheter infections. J Vasc Interv Radiol 2004; 15: 327-334

Hanberger H, Walther S, Leone M, Barie PS, Rello J, Lipman J, Marshall JC, Anzueto A, Sakr Y, Pickkers P, Felleiter P, Engoren M, Vincent JL; EPIC II Group of Investigators. Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the Intensive Care Unit: results from the EPIC II study. Int J Antimicrob Agents, 2011 Oct; 38(4): 331-5

Hebert C, Weber SG. Common approaches to the control of multidrug-resistant organisms other than methicillin-resistant Staphylococcus aureus (MRSA). Infect Dis Clin North Am. 2011 Mar; 25(1): 181-200, HYPERLINK „/pubmed/21316000, Epub 2010 Dec 17

Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. for the National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities. Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007; Infection control and hospital epidemiology November 2008, (29):11 nhsn annual update

Jamieson EM, McCall JM, Whyte LA. Practice 21: Intravenous therapy. In: Jamieson EM, McCall JM, Whyte LA. Clinical nursing practices. 5. Edition, Edinburgh [u.a.]: Elsevier Churchill Livingstone 2007; 169-176

Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intesive care unit. A case-control study, received 16 January 2009; accepted 10 June 2009

Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2002 Jun; 51(2):126-32

Kramer A, Wagenvoort H, Ahrén C, Daniels-Haardt I, Hartemann P, Kobayashi H, Kurcz A, Picazo J, Privitera G, Assadian O. Epidemiology of MRSA and current stategies in Europe and Japan. Institute for Hygiene and Environmental Medicine, University
Greifswald, Germany, GMS Krankenhyg Interdiszip. 2010 Feb 10; 5(1): Doc01


Mayon-White RT et al. An international survey of the prevalence of hospital-acquired infection. J Hosp Infect, 1988, 11 (Supplement A):43–48

MMWR Morbitity and Mortality Weekly Report. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Recommendations and Reports, Oct 25, 2002, (51) No. RR-16

National Institute for Occupational Safety and Health.

NCSL (National Conference of State Legislatures). Medicare Nonpayment for Medical Errors. Washington D.C. 2008

Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994 May 25; 271(20): 1598-601

Plowman RP, Graves N, Robers JA. Hospital Aquired Infection. Office of Health Economics, London 1997

Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultra-structural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168: 400-407

Raad I, Hanna H. Nosocomial infections related to use of intravascular devices inserted for long-term vascular access. In: Mayhall C, ed. Hospital Epidemiology and Infection Control. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999: 165-172

Raad I. Intravascular-catheter-related infections. Lancet 1998; 351: 893-898

Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, Valles J. Evaluation of Outcome of Intravenous Catheter-related Infections in Critically III Patients. Am J Respir Crit Care Med 2000 (162): 1027–1030

Roberts RR, Scott RD 2nd, Cordell R, Colomon SL, Steele L, Kampe LM, Trick WE, Weinstein RA. The use of economic modeling to determine the hospital costs associated with nosocomial infections.

Rosenthal VD, Maki DG. Prospective study of the impact of open and closed infusion systems on rates of central venous catheter-associated bacteremia. Am J Infect Control 2004 May; 32(3): 135-41

Royal College of Nursing (RCN). Standards for infusion therapy. Third edition. The RCN IV Therapy Forum.

Royal College of Nursing. Standards for Infusion Therapy. RCN, London 2005

Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004; 30: 62-67

Scales K. Vascular access: a guide to peripheral venous cannulation. Nurs Stand. 2005; 19(49): 48-52

Schmidt, Unsicker. Lehrbuch Vorklinik, Teil A Anatomie, Biochemie und Physiologie der Zelle. Kap. Medizinische Mikrobiologie, von W. Solbach, Deutscher Ärzte-Verlag GmbH, 2003

Stolecki D. Infusion. In: Kellnhauser E, Juchli L. Thiemes Pflege. Professionalität erleben. Stuttgart, Berlin. Thieme 2004: 1016

Stone PW, Larson E, Kawar LN. A systematic audit of economic evidicen linking nocosomial infections and infection control interventions: 1990-2000. Am J Infect Control 2002; 30:145-52

Tikhomirov E. WHO Programme for the Control of Hospital Infections. Chemiotherapia, 1987, 3:148–151

Uslusoy E., Mete S.: Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study. J Am Acad Nurse Pract. 2008; 20(4): 172-80

van der Hoeck G. Sustained low prevalence of meticillinresistant Staphylococcus aureus upon admission to hospital in the Netherlands. Very low prevalence of MRSA in Dutch population at hospital admission-Study. J Hosp Infect. 2011 Jul 13

Vandijck DM, Depaemelaere M, Labeau SO, Depuydt PO, Annemans L, Buyle FM, Oeyen S, Colpaert KE, Peleman RP, Blot DI, Decruyenaere JM. Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed
bloodstream infection. International Journal of Antimicrobial Agents 2008; 31: 161-165


Wertheim HF, Vos MC, Boelens HA, Voss A, Vandenbroucke-Grauls CM, Meester MH, Kluytmans JA, van Keulen PH, Verbrugh HA: Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect 2004 Apr; 56(4): 321-5

WHO guideline 2002.

World Health Organization, Department of Communicable Disease, Surveillance and Response. Prevention of hospital-acquired infections. A practical guide, 2nd edition, 2002,

World Health Organization. Practical Guidelines for Infection Control in Health Care Facilities. SEARO Regional Publication No. 41, WPRO Regional Publication 2004Clin Infect Dis. 2003 Jun 1;36 (11):1424-32. Epub 2003 May 22

World Health Organization. WHO Guidelines on Hand Hygiene in Health Care. WHO Library Cataloguing-in-Publication Data,

Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 2003 Oct; 290(14):1886-1874

Not all products are registered and approved for sale in all countries or regions. Indications of use may also vary by country and region. Product images are for reference only. Please contact your country representative for product availability and information.